Currently, out of the existing stock ratings of Matthew Caufield - 36 which are a Buy (100%)

Matthew Caufield

Work Performance Price Targets & Ratings Chart

Analyst Matthew Caufield works at HC WAINWRIGHT and is covering the Healthcare sector with 67 price targets and ratings displayed on 6 stocks.

Matthew Caufield's average stock forecast success ratio is 20.37% with an average time for price targets to be met of 55 days.

Most recent stock forecast was given on EYEN, Eyenovia at 18-Aug-2023.

Wall Street Analyst Matthew Caufield

Analyst best performing recommendations are on ISEE.
The best stock recommendation documented was for EYEN (EYENOVIA) at 10/23/2020. The price target of $6 was fulfilled within 69 days with a profit of $2.47 (69.97%) receiving and performance score of 10.14.

Average potential price target upside

ALDX Aldeyra Therapeutics EYEN Eyenovia FDMT ISEE OCUP Ocuphire Pharma OPT

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score


1 months 17 days ago

0/2 (0%)

$10.28 (77.60%)



1 months 17 days ago

0/1 (0%)

$6.42 (84.70%)



$8.32 (124.55%)


5 months 4 days ago

0/5 (0%)

$6.81 (87.08%)


1 years 11 months 7 days ago

0/1 (0%)

$9.48 (75.72%)


4 years 5 months 8 days ago

1/2 (50%)

$9.65 (95.62%)


Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Matthew Caufield is most bullish on?

Potential upside of $25.88 has been obtained for FDMT

Which stock is Matthew Caufield is most reserved on?

Potential downside of $8.32 has been obtained for ALDX (ALDEYRA THERAPEUTICS)

What Year was the first public recommendation made by Matthew Caufield?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart